Friday 6 November 2026 Export VCEL’s income statement to Excel — free account

Vericel Corporation

VCEL Healthcare Biotechnology

Vericel Corporation’s revenue for fiscal 2025 (year ended December 2025) was $276.3 million, up 16.5% from fiscal 2024.

Revenue: +26.5%
EPS: +180.0%
Free cash flow: −19.4%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

54.08 2.30 +4.44%

Follow VCEL

Alert me

Market cap: $2.7B
P/E: 77.8×
Fwd P/E: 72.9×
Dividend yield: —
F-score: 7/9
Altman Z: 8.21
Beneish M: −2.53
Dividend safety: n/a

Overview

Vericel Corporation (VCEL) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Vericel Corporation (VCEL) trades at a P/E ratio of 77.8×. Over the past ten years it has ranged from 0.0× (June 2024) to 5,356× (August 2024); the current reading is higher than 69% of that period. That is above the Biotechnology industry median of 10.3× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/VCEL/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Vericel Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/VCEL/metrics/pe-ratio">Vericel Corporation (VCEL) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	113×	(59.01%)
FY2024	275×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	441×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	60.8×	(34.38%)
Jun 2026	92.7×	23.89%
Mar 2026	74.8×	(33.52%)
Dec 2025	113×	(7.03%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 5,356×

Ten-year median 0.0×

Current reading's percentile 4

Company	P/E ratio
PVLA Palvella Therapeutics, Inc. compare	n/m
PHVS Pharvaris N.V. compare	n/m
BHVN Biohaven Ltd. compare	n/m
VERA Vera Therapeutics, Inc. compare	n/m
CLDX Celldex Therapeutics, Inc. compare	n/m
IMNM Immunome, Inc. compare	n/m
AUPH Aurinia Pharmaceuticals Inc compare	6.8×
ADMA ADMA Biologics Inc compare	16.7×
VCEL Vericel Corporation	77.8×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Vericel Corporation (VCEL) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on VCEL

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on VCEL

Stockrow Weekly